In the brains of AD patients, reduced CB expression was associated with cognitive deterioration and advanced disease stages.<h4>Conclusions</h4>Tau aggregation drives calcium dysregulation and hippocampal neuronal hyperexcitation through reducing CB expression. The gene discussed is MAPT; the disease is Alzheimer disease.